Fluorescent in situ hybridization 1p/19q deletion/imbalance analysis of low-grade and atypical meningiomas

Neurologia Medico-Chirurgica

Volumn 50, Issue 1, 2010, Pages 27-32

  Nagasaka, Toru ^a   Gunji, Masaharu ^a   Hosokai, Noboru ^b   Hayashi, Kumiko ^b   Fujino, Masahiko ^a   Ikeda, Hiroshi ^a   Ito, Masafumi ^a   Inao, Suguru ^a  

^a JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

Author keywords

Chromosomal instability; Chromosome 1p 19q; Fluorescent in situ hybridization; Meningioma

Indexed keywords

ADULT; AGED; ARTICLE; ATYPICAL MENINGIOMA; CANCER GRADING; CHROMOSOMAL INSTABILITY; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; MALE; MENINGIOMA;

ADULT; AGED; AGED, 80 AND OVER; ALLELIC IMBALANCE; CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; DNA MUTATIONAL ANALYSIS; FEMALE; GENE DELETION; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; MUTATION; PREDICTIVE VALUE OF TESTS;

EID: 76749115336     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.50.27     Document Type: Article

References (20)

1. Aubele M, Zitzelsberger H, Szücs S, Werner M, Braselmann H, Hutzler P, Rodenacker K, Lehmann L, Minkus G, Höfler H: Comparative FISH analysis of numerical chromosome 7 abnormalities in 5-micron and 15-micron paraffin-embedded tissue sections from prostatic carcinoma. Histochem Cell Biol 107: 121-126, 1997
2. Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana A, Rey JA: Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosomes Cancer 9: 296-298, 1994
3. Cai DX, Banerjee R, Scheithauer BW, Lohse CM, Kleinschmidt-Demasters BK, Perry A: Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. J Neuropathol Exp Neurol 60: 628-636, 2001
4. de Pender AM, Alers JC, Vissers KJ, de Both NJ, Dinjens WN, van Dekken H: Evaluation of oncogene amplification in intact and truncated cell nuclei of gastro-esophageal cancer cell lines by DNA in situ hybridisation. Acta Histochem 103: 127-138, 2001
5. Hashimoto N, Ichikawa D, Arakawa Y, Date K, Ueda S, Nakagawa Y, Horii A, Nakamura Y, Abe T, Inazawa J: Frequent deletions of material from chromosome arm 1p in oligodendroglial tumors revealed by double-target fluorescence in situ hybridization and microsatellite analysis. Genes Chromosomes Cancer 14: 295-300, 1995
6. Ishino S, Hashimoto N, Fushiki S, Date K, Mori T, Fujimoto M, Nakagawa Y, Ueda S, Abe T, Inazawa J: Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization. Cancer 83: 360-366, 1998
7. Ketter R, Henn W, Niedermayer I, Steilen-Gimbel H, König J, Zang KD, Steudel WI: Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases. J Neurosurg 95: 601-607, 2001
8. Ketter R, Rahnenführer J, Henn W, Kim YJ, Feiden W, Steudel WI, Zang KD, Urbschat S: Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomas. Neurosurgery 62: 61-70, 2008
9. Ketter R, Urbschat S, Henn W, Feiden W, Beerenwinkel N, Lengauer T, Steudel WI, Zang KD, Rahnenführer J: Application of oncogenetic trees mixtures as a biostatistical model of the clonal cytogenetic evolution of meningiomas. Int J Cancer 121: 1473-1480, 2007
10. Kleihues P, Cavenee WK: World Health Organization Classification of Tumours of the Nervous System. Lyon, France, WHO/IARC, 2000, pp 176-184
11. Modha A, Gutin PH: Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 57: 538-550, 2005
12. Nagasaka T, Gunji M, Hosokai N, Hayashi K, Ikeda H, Ito M, Inao S: FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma. Brain Tumor Pathol 24: 1-5, 2007
13. Pfisterer WK, Hank NC, Preul MC, Hendricks WP, Pueschel J, Coons SW, Scheck AC: Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas. Neuro Oncol 6: 290-299, 2004
14. Sayagues JM, Tabernero MD, Maillo A, Diaz P, Rasillo A, Bortoluci A, Gomez-Moreta J, Santos-Briz A, Morales F, Orfao A: Incidence of numerical chromosome aberrations in meningioma tumors as revealed by fluorescence in situ hybridization using 10 chromosome-specific probes. Cytometry 50: 153-159, 2002
15. Sayagues JM, Tabernero MD, Maillo A, Espinosa A, Rasillo A, Diaz P, Ciudad J, Lopez A, Merino M, Goncalves JM, Santos-Briz A, Morales F, Orfao A: Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions? J Mol Diagn 6: 316-325, 2004
16. Simon M, von Deimling A, Larson JJ, Wellenreuther R, Kaskel P, Waha A, Warnick RE, Tew JM Jr, Menon AG: Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res 55: 4696-4701, 1995
17. Stock C, Ambros IM, Mann G, Gadner H, Amann G, Ambros PF: Detection of Ip36 deletions in paraffin sections of neuroblastoma tissues. Genes Chromosomes Cancer 6: 1-9, 1993
18. Sulman EP, Dumanski JP, White PS, Zhao H, Maris JM, Mathiesen T, Bruder C, Cnaan A, Brodeur GM: Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity. Cancer Res 58: 3226-3230, 1998
19. Wada K, Maruno M, Suzuki T, Kagawa N, Hashiba T, Fujimoto Y, Hashimoto N, Izumoto S, Yoshimine T: Chromosomal and genetic aberrations differ with meningioma subtype. Brain Tumor Pathol 21: 127-133, 2004
20. Weber RG, Bostrom J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P: Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci U S A 94: 14719-14724, 1997